We are live on ! Find out more
B

Braslyn Portfolio holdings

AUM $7.81M
1-Year Est. Return 338.68%
This Fund
S&P 500
This Quarter Est. Return
+22.98%
1 Year Est. Return
+338.68%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.35M
AUM Growth
-$184M
Cap. Flow
-$184M
Cap. Flow %
-7,852.54%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$184M

Sector Composition

1 Technology 90.88%
2 Healthcare 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSG icon
1
Inseego
INSG
$123M
$2.13M 90.88%
761,483
– –
TNGX icon
2
Tango Therapeutics
TNGX
$4.5B
$214K 9.12%
26,961
– –
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-3,135,966
Closed -$184M

Similar funds

AMG
Ace Management Global Sao Paulo, Brazil $7.88M AUM 47.04% 1-Year Est. Return
XS
XR Securities Chicago, Illinois $5.35M AUM 26.1% 1-Year Est. Return
SFG
Susquehanna Financial Group Bala Cynwyd, Pennsylvania $10.9M AUM
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
ZIMP
Zimmermann Investment Management & Planning New Cumberland, Pennsylvania $2.27M AUM 29.81% 1-Year Est. Return
RCI
Ridgeback Capital Investments Miami Beach, Florida $560K AUM
LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return

Braslyn's Q1 2024 Portfolio in Review

As of Q1 2024, Braslyn held 3 positions worth $2.35M, down 99% from $186M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Braslyn withdrew a net $184M in Q1 2024, closing 1 position. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $184M position sold in full.

By sector, the portfolio is most concentrated in Technology at 91% of assets, up from 0.9% a quarter earlier, followed by Healthcare.

  • Braslyn fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $184M.
  • Braslyn's ten largest holdings make up 100% of its $2.35M portfolio in Q1 2024.
  • Braslyn opened 0 new positions and closed 1 in Q1 2024.
  • Braslyn's portfolio value fell 99% quarter-over-quarter to $2.35M.

Based on Braslyn's 13F filing for Q1 2024, filed 15 May 2024.